At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Oxymetazolinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption During Functional Endoscopic or Turbinate Reduction Surgery or Adenoidectomy
In Brief
A clinical study evaluating Oxymetazoline for Adenoidectomy and 2 related conditions. Completed, enrolled 30 participants across 1 site.
Detailed Summary
This proposed study will assess the hemodynamic effects and measure the systemic absorption of topically applied oxymetazoline in patients undergoing functional endoscopic sinus surgery, turbinate surgery, or adenoidectomy. These patients will be receiving oxymetazoline as standard of care during the surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 2015
Enrollment StartDec 2015
Primary CompletionApr 2017
TodayJul 2026
First PostedMay 27, 2015
Enrollment StartDec 1, 2015
Primary CompletionApr 20, 2017
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 11.1 years ago
Interventions
Oxymetazolinedrug